Advertisement

Ätiologie und Pathogenese des Uterus myomatosus

  • M. Kolben

Zusammenfassung

Leiomyome des Uterus stellen gutartige Tumoren aus glatter Muskulatur und bindegewebigem Anteil dar und gehören zu der Gruppe nichtepithelialer uteriner Tumoren (s. Übersicht). Leiomyome kommen bei Frauen nach dem 30. Lebensjahr in 20–30% sowie nach dem 50. Lebensjahr in 40% vor und sind daher die häufigsten uterinen Neoplasien.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Anania CA, Stewart EA, Quade BJ, Hill JA, Nowak RA (1997) Expression of fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Mol Hum Reprod 3: 685–691PubMedCrossRefGoogle Scholar
  2. Fujita M (1985) Histological and biochemical studies of collagen in human uterine leiomyomas. Hokkaido Ogaku Zasshi 60: 602–615Google Scholar
  3. Lessl M, Klotzbuecher M, Schoen S, Reles A, Stockemann K, Fuhrmann U (1997) Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium. J Clin Endocrinol Metab 82: 2596–2600PubMedCrossRefGoogle Scholar
  4. Palan PR, Mikhail M, Romney SL (1989) Decreased beta-carotene tissue levels in leiomyomas and cancers of reproductive and nonreproductive organs. Am J Obstet Gynecol 161: 1649–1652PubMedGoogle Scholar
  5. Popivanova P (1989) Progesterone secretion in healthy women and in women with uterine myoma. Akush Ginekol Sofia 28: 54–57Google Scholar
  6. Rein MS, Barbieri RL, Friedman AJ (1995) Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 172: 14–18PubMedCrossRefGoogle Scholar
  7. Stewart EA, Nowak RA (1996) Leiomyoma-related bleeding: a classic hypothesis updated for the molecular area. Hum Reprod Update 2: 295–306PubMedCrossRefGoogle Scholar
  8. Stewart EA, Nowak RA (1998) New concepts in the treatment of uterine leiomyomas. Obstet Gynecol 92: 624–627PubMedCrossRefGoogle Scholar
  9. Tamaya F, Fujimoto J, Okada H (1985) Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium. Acta Obstet Gynecol Scand 64: 307–309PubMedCrossRefGoogle Scholar
  10. Tiltman AJ (1997) Smooth muscle neoplasms of the uterus. Curr Opin Obstet Gynecol 9: 48–51PubMedCrossRefGoogle Scholar
  11. Tommola P, Pekonen F, Rutanen EM (1989) Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata. Obstet Gynecol 74: 658–662PubMedGoogle Scholar
  12. de Vos S, Wilczynski SP, Fleischhacker M, Koeffler P (1994) p53 alterations in uterine leiomyosarcomas versus leiomyomas. Gynecol Oncol 54: 205–208PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • M. Kolben

There are no affiliations available

Personalised recommendations